|
1
|
György B, Szabó TG, Pásztói M, Pál Z,
Misják P, Aradi B, László V, Pállinger E, Pap E, Kittel A, et al:
Membrane vesicles, current state-of-the-art: Emerging role of
extracellular vesicles. Cell Mol Life Sci. 68:2667–2688. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nozaki T, Sugiyama S, Koga H, Sugamura K,
Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H and Ogawa H:
Significance of a multiple biomarkers strategy including
endothelial dysfunction to improve risk stratification for
cardiovascular events in patients at high risk for coronary heart
disease. J Am Coll Cardiol. 54:601–608. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hansson GK: Inflammation, atherosclerosis
and coronary artery disease. N Engl J Med. 352:1685–1695. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liuzzo G, Biasucci LM, Gallimore JR,
Grillo RL, Rebuzzi AG, Pepys MB and Maseri A: The prognostic value
of C-reactive protein and serum amyloid a protein in severe
unstable angina. N Engl J Med. 331:417–424. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lindahl B, Toss H, Siegbahn A, Venge P and
Wallentin L: Markers of myocardial damage and inflammation in
relation to long-term mortality in unstable coronary artery
disease. FRISC Study Group. Fragmin during Instability in Coronary
Artery Disease. N Engl J Med. 343:1139–1147. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Habersberger J, Strang F, Scheichl A, Htun
N, Bassler N, Merivirta RM, Diehl P, Krippner G, Meikle P,
Eisenhardt SU, et al: Circulating microparticles generate and
transport monomeric C-reactive protein in patients with myocardial
infarction. Cardiovasc Res. 96:64–72. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Inoue T, Komoda H, Kotooka N, Morooka T,
Fujimatsu D, Hikichi Y, Soma R, Uchida T and Node K: Increased
circulating platelet-derived microparticles are associated with
stent-induced vascular inflammation. Atherosclerosis. 196:469–476.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Biasucci LM, Porto I, Di Vito L, De Maria
GL, Leone AM, Tinelli G, Tritarelli A, Di Rocco G, Snider F,
Capogrossi MC and Crea F: Differences in microparticle release in
patients with acute coronary syndrome and stable angina. Circ J.
76:2174–2182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Leroyer AS, Rautou PE, Silvestre JS,
Castier Y, Lesèche G, Devue C, Duriez M, Brandes RP, Lutgens E,
Tedgui A and Boulanger CM: CD40 ligand+ microparticles from human
atherosclerotic plaques stimulate endothelial proliferation and
angiogenesis a potential mechanism for intraplaque
neovascularization. J Am Coll Cardiol. 52:1302–1311. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stępień E, Stankiewicz E, Zalewski J,
Godlewski J, Zmudka K and Wybrańska I: Number of microparticles
generated during acute myocardial infarction and stable angina
correlates with platelet activation. Arch Med Res. 43:31–35. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pollack CV Jr, Diercks DB, Roe MT and
Peterson ED: American College of Cardiology; American Heart
Association: 2004 American college of cardiology/American Heart
Association guidelines for the management of patients with
ST-elevation myocardial infarction: Implications for emergency
department practice. Ann Emerg Med. 45:363–376. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Stringer KA: TIMI grade flow, mortality,
and the GUSTO-III trial. Pharmacotherapy. 18:699–705.
1998.PubMed/NCBI
|
|
13
|
Gensini GG: A more meaningful scoring
system for determining the severity of coronary heart disease. Am J
Cardiol. 51:6061983. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Levine GN, Bates ER, Blankenship JC,
Bailey SR, Bittl JA, Cercek B, Chambers CE, Ellis SG, Guyton RA,
Hollenberg SM, et al: 2011 ACCF/AHA/SCAI Guideline for percutaneous
coronary intervention. A report of the American college of
cardiology foundation/American heart association task force on
practice guidelines and the society for cardiovascular angiography
and interventions. J Am Coll Cardiol. 58:e44–e122. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen S, Guo L, Cui M, Sun L and Mi L:
Dynamic changes in serum angiopoietin-1, angiopoietin-2 and
angiopoietin-2/angiopoietin-1 ratio in acute myocardial infarction
patients treated with primary percutaneous coronary intervention.
Biomarkers. 17:441–446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Robert S, Poncelet P, Lacroix R, Arnaud L,
Giraudo L, Hauchard A, Sampol J and Dignat-George F:
Standardization of platelet-derived microparticle counting using
calibrated beads and a Cytomics FC500 routine flow cytometer: A
first step towards multicenter studies? J Thromb Haemost.
7:190–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Empana JP, Boulanger CM, Tafflet M, Renard
JM, Leroyer AS, Varenne O, Prugger C, Silvain J, Tedgui A, Cariou
A, et al: Microparticles and sudden cardiac death due to coronary
occlusion. The TIDE (Thrombus and Inflammation in sudden DEath)
study. Eur Heart J Acute Cardiovasc Care. 4:28–36. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang K, Zuo G, Zheng L, Zhang C, Wang D,
Cao Z, Hu S and Du X: Effects of tirofiban on platelet activation
and endothelial function in patients with ST-elevation myocardial
infarction undergoing primary percutaneous coronary intervention.
Cell Biochem Biophys. 71:135–142. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lacroix R, Robert S, Poncelet P, Kasthuri
RS, Key NS and Dignat-George F: ISTH SSC Workshop: Standardization
of platelet-derived microparticle enumeration by flow cytometry
with calibrated beads: Results of the international society on
thrombosis and haemostasis SSC collaborative workshop. J Thromb
Haemost. 8:2571–2574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Robert S, Lacroix R, Poncelet P, Harhouri
K, Bouriche T, Judicone C, Wischhusen J, Arnaud L and Dignat-George
F: High-sensitivity flow cytometry provides access to standardized
measurement of small-size microparticles-brief report. Arterioscler
Thromb Vasc Biol. 32:1054–1058. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Biasucci LM, Porto I, Di Vito L, De Maria
GL, Leone AM, Tinelli G, Tritarelli A, Di Rocco G, Snider F,
Capogrossi MC and Crea F: Differences in microparticle release in
patients with acute coronary syndrome and stable angina. Circ J.
76:2174–2182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sinauridze EI, Kireev DA, Popenko NY,
Pichugin AV, Panteleev MA, Krymskaya OV and Ataullakhanov FI:
Platelet microparticle membranes have 50- to 100-fold higher
specific procoagulant activity than activated platelets. Thromb
Haemost. 97:425–434. 2007.PubMed/NCBI
|
|
23
|
Angelillo-Scherrer A: Leukocyte-derived
microparticles in vascular homeostasis. Circ Res. 110:356–369.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Vidal C, Spaulding C, Picard F, Schaison
F, Melle J, Weber S and Fontenay-Roupie M: Flow cytometry detection
of platelet procoagulation activity and microparticles in patients
with unstable angina treated by percutaneous coronary angioplasty
and stent implantation. Thromb Haemost. 86:784–790. 2001.PubMed/NCBI
|
|
25
|
Lacroix R and Dignat-George F:
Microparticles as a circulating source of procoagulant and
fibrinolytic activities in the circulation. Thromb Res. 129(Suppl
2): S27–S29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lacroix R, Plawinski L, Robert S, Doeuvre
L, Sabatier F, de Lizarrondo Martinez S, Mezzapesa A, Anfosso F,
Leroyer AS, Poullin P, et al: Leukocyte- and endothelial-derived
microparticles: A circulating source for fibrinolysis.
Haematologica. 97:1864–1872. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tan KT, Tayebjee MH, Lim HS and Lip GY:
Clinically apparent atherosclerotic disease in diabetes is
associated with an increase in platelet microparticle levels.
Diabet Med. 22:1657–1662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hron G, Kollars M, Weber H, Sagaster V,
Quehenberger P, Eichinger S, Kyrle PA and Weltermann A: Tissue
factor-positive microparticles: Cellular origin and association
with coagulation activation in patients with colorectal cancer.
Thromb Haemost. 97:119–123. 2007.PubMed/NCBI
|
|
29
|
Pereira J, Alfaro G, Goycoolea M, Quiroga
T, Ocqueteau M, Massardo L, Pérez C, Sáez C, Panes O, Matus V and
Mezzano D: Circulating platelet-derived microparticles in systemic
lupus erythematosus. Association with increased thrombin generation
and procoagulant state. Thromb Haemost. 95:94–99. 2006.PubMed/NCBI
|
|
30
|
Chen J, Zhang Y, Liu J, Chen MH, Guo YL,
Zhu CG, Xu RX, Dong Q and Li JJ: Role of lipoprotein(a) in
predicting the severity of new on-set coronary artery disease in
type 2 diabetics: A Gensini score evaluation. Diab Vasc Dis Res.
12:258–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Mori T, Sasaki J, Kawaguchi H, Handa K,
Takada Y, Matsunaga A, Kono S and Arakawa K: Serum glycoproteins
and severity of coronary atherosclerosis. Am Heart J. 129:234–238.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Handa K, Kono S, Saku K, Sasaki J, Kawano
T, Sasaki Y, Hiroki T and Arakawa K: Plasma fibrinogen levels as an
independent indicator of severity of coronary atherosclerosis.
Atherosclerosis. 77:209–213. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Woloshin S and Schwartz LM: Distribution
of C-reactive protein values in the United States. N Engl J Med.
352:1611–1613. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rohde LE, Hennekens CH and Ridker PM:
Survey of C-reactive protein and cardiovascular risk factors in
apparently healthy men. Am J Cardiol. 84:1018–1022. 1999.
View Article : Google Scholar : PubMed/NCBI
|
